| Year |
Citation |
Score |
| 2022 |
Mastrogiacomo R, Trigilio G, Devroye C, Dautan D, Ferretti V, Losi G, Caffino L, Orso G, Marotta R, Maltese F, Vitali E, Piras G, Forgiarini A, Pacinelli G, Lia A, et al. Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia. Molecular Psychiatry. PMID 35821415 DOI: 10.1038/s41380-022-01683-8 |
0.697 |
|
| 2021 |
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok AH, McCutcheon RA, Jauhar S, Bonoldi I, Gudbrandsen M, Daly E, van Amelsvoort T, Van Den Bree M, Owen MJ, Turkheimer F, Papaleo F, et al. Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. Molecular Psychiatry. PMID 34158623 DOI: 10.1038/s41380-021-01192-0 |
0.664 |
|
| 2021 |
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok A, McCutcheon RA, Jauhar S, Bonoldi I, Gudbrandsen M, Daly E, van Amelsvoort T, Van Den Bree M, Owen MJ, Turkheimer F, Papaleo F, et al. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. Molecular Psychiatry. PMID 33981004 DOI: 10.1038/s41380-021-01108-y |
0.655 |
|
| 2020 |
Cathala A, Devroye C, Robert É, Vallée M, Revest JM, Artigas F, Spampinato U. Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways. Neuropharmacology. 180: 108309. PMID 32956675 DOI: 10.1016/J.Neuropharm.2020.108309 |
0.46 |
|
| 2019 |
Leggio GM, Torrisi SA, Mastrogiacomo R, Mauro D, Chisari M, Devroye C, Scheggia D, Nigro M, Geraci F, Pintori N, Giurdanella G, Costa L, Bucolo C, Ferretti V, Sortino MA, et al. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans. Molecular Psychiatry. PMID 31492942 DOI: 10.1038/S41380-019-0511-4 |
0.656 |
|
| 2019 |
Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/J.Bbi.2019.06.006 |
0.713 |
|
| 2018 |
Cathala A, Devroye C, Drutel G, Revest JM, Artigas F, Spampinato U. Serotonin receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons. Experimental Neurology. 311: 57-66. PMID 30257183 DOI: 10.1016/J.Expneurol.2018.09.015 |
0.399 |
|
| 2017 |
Devroye C, Cathala A, Piazza PV, Spampinato U. The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research. Pharmacology & Therapeutics. PMID 28757154 DOI: 10.1016/J.Pharmthera.2017.07.014 |
0.643 |
|
| 2017 |
Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U. Opposite controls of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors. Neuropharmacology. PMID 28390892 DOI: 10.1016/J.Neuropharm.2017.04.001 |
0.67 |
|
| 2016 |
Devroye C, Cathala A, Haddjeri N, Rovera R, Vallée M, Drago F, Piazza PV, Spampinato U. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia. Neuropharmacology. 109: 59-68. PMID 27260325 DOI: 10.1016/J.Neuropharm.2016.05.024 |
0.693 |
|
| 2015 |
Devroye C, Cathala A, Di Marco B, Caraci F, Drago F, Piazza PV, Spampinato U. Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow. Neuropharmacology. 97: 329-37. PMID 26116760 DOI: 10.1016/J.Neuropharm.2015.06.012 |
0.639 |
|
| 2015 |
Devroye C, Cathala A, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow. Neuropharmacology. 89: 375-81. PMID 25446572 DOI: 10.1016/j.neuropharm.2014.10.016 |
0.611 |
|
| 2015 |
Cathala A, Devroye C, Maitre M, Piazza PV, Abrous DN, Revest JM, Spampinato U. Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. Addiction Biology. 20: 445-57. PMID 24661380 DOI: 10.1111/Adb.12137 |
0.639 |
|
| 2014 |
Cathala A, Devroye C, Maitre M, Piazza P, Abrous D, Revest J, Spampinato U. P.6.c.003 Serotonin 2C receptor inhibits dopamine transmission in the nucleus accumbens independently of dopamine release: studies with cocaine European Neuropsychopharmacology. 24: S676. DOI: 10.1016/S0924-977X(14)71089-2 |
0.378 |
|
| Show low-probability matches. |